Carney complex (CNC), is an autosomal dominant multiple neoplasia and lentiginosis syndrome. We aimed to identify risk factors associated with the occurrence and recurrence of cardiac myxomas, the predominant cause of death in CNC patients.
Patients with CNC were monitored prospectively between 1995 and 2020 for the development of cardiac myxomas.
Of the 319 patients studied, 136 (42.6%) developed myxomas. The mean age at diagnosis was 28.7 ± 16.6 years in females and 25.0 ± 16.4 years in males. By age 30, 35% of females and 45% of males had at least one myxoma. The CNC-related lesions, lentigines, cutaneous, mucosal, or breast myxomas, thyroid nodules, pituitary adenoma, and schwannoma were significantly more frequent (all p < 0.05) among patients with myxomas. Forty-four percent of patients had recurrences; nearly all within the first 8 and 16 years for males and females, respectively. Recurrences were more common in females.
This is the largest study to date and provides the first-time risk estimates by age and gender for cardiac myxomas in CNC patients. Cardiac myxomas are common by age 30 and often recur, especially in women, but the risk drops in 10 to 20 years. These findings may guide patient counseling, screening intervals, and surgical approaches.
Clinical Trial Registration
Clinical Trial Registration: Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease and the Carney complex, Registration number: NCT00001452 URL: https://clinicaltrials.gov/ct2/show/NCT00001452.
Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore). 1985;64:270–283.
Bain J. “Carney’s complex”. Mayo Clin Proc. 1986;61:508.
Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 2001;86:4041–4046.
Bertherat J, Horvath A, Groussin L, et al. Mutations in regulatory subunit type 1A of cyclic adenosine 5’-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab. 2009;94:2085–2091.
Stratakis CA. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the “complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas” (Carney complex). Ann N Y Acad Sci. 2002;968:3–21.
Stratakis CA, Carney JA, Lin JP, et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest. 1996;97:699–705.
Matyakhina L, Pack S, Kirschner LS, et al. Chromosome 2 (2p16) abnormalities in Carney complex tumours. J Med Genet. 2003;40:268–277.
Forlino A, Vetro A, Garavelli L, et al. PRKACB and Carney complex. N Engl J Med. 2014;370:1065–1067.
Sarjeant JM, Butany J, Cusimano RJ. Cancer of the heart: epidemiology and management of primary tumors and metastases. Am J Cardiovasc Drugs. 2003;3:407–421.
Briassoulis G, Kuburovic V, Xekouki P, et al. Recurrent left atrial myxomas in Carney complex: a genetic cause of multiple strokes that can be prevented. J Stroke Cerebrovasc Dis. 2012;21:914 e911–918.
Espiard S, Bertherat J. Carney complex. Front Horm Res. 2013;41:50–62.
Bandettini WP, Karageorgiadis AS, Sinaii N, et al. Growth hormone and risk for cardiac tumors in Carney complex. Endocr Relat Cancer. 2016;23:739–746.
Kwon OY, Kim GJ, Jang WS, Lee YO, Cho JY, Lee JT. Fourth recurrence of cardiac myxoma in a patient with the Carney complex. Korean J Thorac Cardiovasc Surg. 2016;49:119–121.
Mahilmaran A, Seshadri M, Nayar PG, Sudarsana G, Abraham KA. Familial cardiac myxoma: Carney’s complex. Tex Heart Inst J. 2003;30:80–82.
Stratakis CA, Raygada M. Carney complex. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews. Seattle: University of Washington; 1993.
Gammie JS, Abrishamchian AR, Griffith BP. Cardiac autotransplantation and radical bi-atrial resection for recurrent atrial myxoma. Ann Thorac Surg. 2007;83:1545–1547.
Roselli EE. Reoperative cardiac surgery: challenges and outcomes. Tex Heart Inst J. 2011;38:669–671.
Russell JL, LeBlanc JG, Sett SS, Potts JE. Risks of repeat sternotomy in pediatric cardiac operations. Ann Thorac Surg. 1998;66:1575–1578.
Espiard S, Vantyghem MC, Assie G, et al. Frequency and Incidence of Carney complex manifestations: a prospective multicenter study with a three-year follow-up. J Clin Endocrinol Metab. 2020;105:dgaa002.
Carney JA. Differences between nonfamilial and familial cardiac myxoma. Am J Surg Pathol. 1985;9:53–55.
Stratakis CA, Courcoutsakis NA, Abati A, et al. Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab. 1997;82:2037–2043.
Carney JA, Lyssikatos C, Seethala RR, et al. The spectrum of thyroid gland pathology in Carney complex: the importance of follicular carcinoma. Am J Surg Pathol. 2018;42:587–594.
Wang H, Li Q, Xue M, Zhao P, Cui J. Cardiac myxoma: a rare case series of 3 patients and a literature review. J Ultrasound Med. 2017;36:2361–2366.
Kamilaris CDC, Faucz FR, Voutetakis A, Stratakis CA. Carney complex. Exp Clin Endocrinol Diabetes. 2019;127:156–164.
We would like to thank all of the Carney complex patients and their families for participating in this study. This work was supported by the research project Z01-HD008920 (principal investigator: C.A.S.) of the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH) (Bethesda, MD, USA). The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.
C.A.S. holds patents on technologies involving PRKAR1A and related genes; his laboratory has also received research funding support by Pfizer Inc. for work unrelated to this subject investigation. The other authors declare no conflicts of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Pitsava, G., Zhu, C., Sundaram, R. et al. Predicting the risk of cardiac myxoma in Carney complex. Genet Med (2020). https://doi.org/10.1038/s41436-020-00956-3
- Carney complex (CNC)
- cardiac myxoma